The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression

Immunobiology

Volumn 215, Issue 9-10, 2010, Pages 812-820

  Puig Kröger, Amaya ^a   Aguilera Montilla, Noemi ^a   Martínez Nuñez, Rocío ^a   Domínguez Soto, Angeles ^a   Sánchez Cabo, Fátima ^b   Martín Gayo, Enrique ^c   Zaballos, Angel ^d   Toribio, María L ^c   Groner, Yoram ^e   Ito, Yoshiaki ^f   Dopazo, Ana ^b   Corcuera, María T ^g   Alonso Martín, María J ^b   Vega, Miguel A ^g   Corbí, Angel L ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

IL 8; Innate immunity; Myeloid; RUNX; Transcription

Indexed keywords

ALPHA5 INTEGRIN; GLYCOPROTEIN P 15095; INTERLEUKIN 18; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN P33; PROTEIN P44; RNA; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; DENDRITIC CELL; DOWN REGULATION; EMBRYO; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSACTIVATION;

ANIMALS; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; CHEMOTAXIS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; COS CELLS; DENDRITIC CELLS; DOWN-REGULATION; HEK293 CELLS; HUMANS; INTERLEUKIN-8; MONOCYTES; MUTAGENESIS, SITE-DIRECTED; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; U937 CELLS;

EID: 77955472467     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.05.018     Document Type: Article

References (50)

1. Alarcon-Riquelme M.E. A RUNX trio with a taste for autoimmunity. Nat. Genet. 2003, 35:299-300.
2. Bae S.C., Ogawa E., Maruyama M., Oka H., Satake M., Shigesada K., Jenkins N.A., Gilbert D.J., Copeland N.G., Ito Y. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 1994, 14:3242-3252.
3. Bangsow C., Rubins N., Glusman G., Bernstein Y., Negreanu V., Goldenberg D., Lotem J., Ben-Asher E., Lancet D., Levanon D., Groner Y. The RUNX3 gene-sequence, structure and regulated expression. Gene 2001, 279:221-232.
4. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA 2004, 101:16016-16021.
5. Bruhn L., Munnerlyn A., Grosschedl R. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev. 1997, 11:640-653.
6. Coffman J.A. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol. Int. 2003, 27:315-324.
7. Collins A., Littman D.R., Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 2009, 9:106-115.
8. de Bruijn M.F., Speck N.A. Core-binding factors in hematopoiesis and immune function. Oncogene 2004, 23:4238-4248.
9. Djuretic I.M., Levanon D., Negreanu V., Groner Y., Rao A., Ansel K.M. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 2007, 8:145-153.
10. Dominguez-Soto A., Relloso M., Vega M.A., Corbi A.L., Puig-Kroger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology 2005, 210:133-139.
11. Dominguez-Soto A., Puig-Kroger A., Vega M.A., Corbi A.L. PU.1 regulates the tissue-specific expression of dendritic cell-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin. J. Biol. Chem. 2005, 280:33123-33131.
12. Durst K.L., Hiebert S.W. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 2004, 23:4220-4224.
13. Ehlers M., Laule-Kilian K., Petter M., Aldrian C.J., Grueter B., Wurch A., Yoshida N., Watanabe T., Satake M., Steimle V. Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes. J. Immunol. 2003, 171:3594-3604.
14. Fainaru O., Shseyov V., Hantisteanu S., Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc. Natl. Acad. Sci. USA 2005, 102:10598-10603.
15. Fainaru O., Woolf E., Lotem J., Yarmus M., Brenner O., Goldenberg D., Negreanu V., Bernstein Y., Levanon D., Jung S., Groner Y. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 2004, 23:969-979.
16. Gattenloehner S., Chuvpilo S., Langebrake C., Reinhardt D., Muller-Hermelink H.K., Serfling E., Vincent A., Marx A. Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. Blood 2007, 110:2027-2033.
17. Grueter B., Petter M., Egawa T., Laule-Kilian K., Aldrian C.J., Wuerch A., Ludwig Y., Fukuyama H., Wardemann H., Waldschuetz R., Moroy T., Taniuchi I., Steimle V., Littman D.R., Ehlers M. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells. J. Immunol. 2005, 175:1694-1705.
18. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
19. Huang G., Shigesada K., Ito K., Wee H.J., Yokomizo T., Ito Y. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 2001, 20:723-733.
20. Inoue K., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., Iseda T., Kawaguchi S., Ogawa M., Bae S.C., Yamashita N., Itohara S., Kudo N., Ito Y. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 2002, 5:946-954.
21. Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., Huang C., Shah N., Inoue M., Rajnakova A., Hiong K.C., Peh B.K., Han H.C., Ito T., Teh M., Yeoh K.G., Ito Y. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005, 65:7743-7750.
22. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 2004, 23:4198-4208.
23. Ito Y. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 2008, 99:33-76.
24. Kitabayashi I., Yokoyama A., Shimizu K., Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 1998, 17:2994-3004.
25. Le X.F., Groner Y., Kornblau S.M., Gu Y., Hittelman W.N., Levanon D., Mehta K., Arlinghaus R.B., Chang K.S. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway. J. Biol. Chem. 1999, 274:21651-21658.
26. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., Bernstein Y., Goldenberg D., Xiao C., Fliegauf M., Kremer E., Otto F., Brenner O., Lev-Tov A., Groner Y. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 2002, 21:3454-3463.
27. Levanon D., Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene 2004, 23:4211-4219.
28. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
29. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
30. Otto F., Lubbert M., Stock M. Upstream and downstream targets of RUNX proteins. J. Cell. Biochem. 2003, 89:9-18.
31. Peterson L.F., Wang Y., Lo M.C., Yan M., Kanbe E., Zhang D.E. The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation. Leukemia 2007, 21:2010-2019.
32. Puig-Kroger A., Dominguez-Soto A., Martinez-Munoz L., Serrano-Gomez D., Lopez-Bravo M., Sierra-Filardi E., Fernandez-Ruiz E., Ruiz-Velasco N., Ardavin C., Groner Y., Tandon N., Corbi A.L., Vega M.A. RUNX3 negatively regulates CD36 expression in myeloid cell lines. J. Immunol. 2006, 177:2107-2114.
33. Puig-Kroger A., Sanchez-Elsner T., Ruiz N., Andreu E.J., Prosper F., Jensen U.B., Gil J., Erickson P., Drabkin H., Groner Y., Corbi.A.L. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 2003, 102:3252-3261.
34. Shigesada K., van de Sluis B., Liu P.P. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Oncogene 2004, 23:4297-4307.
35. Shimada H., Ichikawa H., Nakamura S., Katsu R., Iwasa M., Kitabayashi I., Ohki M. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8, overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood 2000, 96:655-663.
36. Shimada H., Ichikawa H., Ohki M. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis. Leukemia 2002, 16:874-885.
37. Spender L.C., Whiteman H.J., Karstegl C.E., Farrell P.J. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 2005, 24:1873-1881.
38. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., Zaidi S.K., Young D.W., Choi J.Y., Pockwinse S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
39. Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M., Kimura K., Shiina M., Sato K., Kumasaka T., Yamamoto M., Ishii S., Ogata K. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell 2001, 104:755-767.
40. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002, 111:621-633.
41. Telfer J.C., Hedblom E.E., Anderson M.K., Laurent M.N., Rothenberg E.V. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 2004, 172:4359-4370.
42. van Wijnen A.J., Stein G.S., Gergen J.P., Groner Y., Hiebert S.W., Ito Y., Liu P., Neil J.C., Ohki M., Speck N. Nomenclature for Runt-related (RUNX) proteins. Oncogene 2004, 23:4209-4210.
43. Westendorf J.J., Hiebert S.W. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J. Cell. Biochem. Suppl. 1999, 32-33:51-58.
44. Woolf E., Brenner O., Goldenberg D., Levanon D., Groner Y. Runx3 regulates dendritic epidermal T cell development. Dev. Biol. 2006, 15:703-714.
45. Woolf E., Xiao C., Fainaru O., Lotem J., Rosen D., Negreanu V., Bernstein Y., Goldenberg D., Brenner O., Berke G., Levanon D., Groner Y. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 2003, 100:7731-7736.
46. Wotton S., Terry A., Kilbey A., Jenkins A., Herzyk P., Cameron E., Neil J.C. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene 2008, 27:5856-5866.
47. Yagi R., Chen L.F., Shigesada K., Murakami Y., Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999, 18:2551-2562.
48. Yarmus M., Woolf E., Bernstein Y., Fainaru O., Negreanu V., Levanon D., Groner Y. Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3. Proc. Natl. Acad. Sci. USA 2006, 103:7384-7389.
49. Zhang F., Meng G., Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 2008, 9:1297-1306.
50. Zhang Y.W., Bae S.C., Huang G., Fu Y.X., Lu J., Ahn M.Y., Kanno Y., Kanno T., Ito Y. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol. Cell. Biol. 1997, 17:4133-4145.